12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

Auric Pharma, Neuro-Biotech Corp. deal

Neuro-Biotech said its board has decided not to proceed with Auric's offer to acquire all outstanding shares of the biotech after the companies were unable to agree on a common direction for Neuro-Biotech....

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >